Terpenoid Therapeutics, Inc. — Form D
Terpenoid Therapeutics, Inc. of CORALVILLE, IA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-29. The offering totals $5.0M, of which $803K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-11-29
- Form: D
- Accession: 0001480768-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $803K
- Remaining: $4.2M
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2012-05-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-299743
Issuer
- Name: Terpenoid Therapeutics, Inc.
- CIK: 0001480768
- Entity type: Corporation
- Jurisdiction: IOWA
- Incorporated: 2005
- Address: 2500 CROSSPARK ROAD, CORALVILLE, IA, 52241
- Phone: 319-321-6848
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Steven D Collins | Director | Coralville, IA |
| Mark J Drish | Director | Coralville, IA |
| Raymond J Hohl | Director | Coralville, IA |
| Curt J Nelson | Director | Coralville, IA |
| David F Weimer | Director | Coralville, IA |
| Steven D Collins | Executive Officer | Coralville, IA |
| Raymond J Hohl | Executive Officer | Coralville, IA |
| Jeffrey D Neighbors | Director | Coralville, IA |
| Jeffrey D Neighbors | Executive Officer | Coralville, IA |
| David J Wiemer | Director | Coralville, IA |
| David J Wiemer | Executive Officer | Coralville, IA |
| Robert W Karr | Director | SAINT LOUIS, MO |
| Robert W Karr | Executive Officer | SAINT LOUIS, MO |
| David F Wiemer | Director | CORALVILLE, IA |
| David F Wiemer | Executive Officer | CORALVILLE, IA |
Other filings by this issuer (2)
More